The trend of globalization spreads domestic pharmaceutical companies need to complement each other to expand market share

As the globalization trend continues to spread, the trend of MNCs acquiring M&A in China has intensified in recent years. Some local governments have rushed to attract foreign capital under the influence of distorted political achievements, resulting in a large number of China’s competitiveness and high speed. The growing leading enterprises in the equipment industry have been controlled by multinational corporations, their own brands and innovation capabilities have gradually disappeared, and the huge equipment manufacturing market is being occupied by multinational corporations.

In fact, in the course of the development of pharmaceutical companies in China, besides starting with the European and American mature market standards as self-requirements and self-regulation in terms of production facilities and other hardware facilities, more and more Chinese companies have developed software-product technology and product innovation. More expectation and investment. The result of this soft and hard progress will surely be the upgrading of China's pharmaceutical industry. Some authoritative organizations also believe that in the next 10 years, China’s increase in the world’s pharmaceutical market share and the short-term development of China’s pharmaceutical economy over the world’s average speed will increase the number of multinational companies (such as biopharmaceutical companies) related to the pharmaceutical industry. Greater China's investment in China has accelerated the upgrading of China's pharmaceutical industry while winning commercial interests.

Cai Weici, vice president of the China Machinery Industry Federation, believes that the current efforts, depth, breadth and goal of foreign companies entering the Chinese machinery manufacturing industry have undergone profound changes. Its purpose is not only to occupy the Chinese market, but also to integrate China's machinery manufacturing into its global industrial chain. It is fundamentally necessary to eliminate the possibility of competition between Chinese companies in the future.

Experts in the industry pointed out that it is necessary to hold shares, the other party must be the leading enterprise in the industry, and the future earnings must exceed 15%. These three points have become the basic point of MNCs' current acquisition activities in China. It is from this basic point that at this stage, multinational corporations take advantage of this rare opportunity for China’s state-owned enterprise reforms to enter the crucial stage, and “eat and live” a number of industry leaders in the Chinese equipment manufacturing industry by capital operation to create their own global industry. Chain and realize the monopoly on the Chinese market.

Domestic pharmaceutical equipment companies must face the impact of multinational corporations, continuously strengthen their own competitiveness, learn from each other's strengths, maintain their own advantages, learn from the experience of foreign companies, and break the monopoly.

Intelligent Multi-knife Foam Cutting Machine

Adhere to the service tenet of "quality-based, honesty, continuous innovation, and win-win cooperation", and sincerely provide users with technical guidance, installation, commissioning, and production, and you can solve the problems you encounter in the process of using the equipment in a timely manner.China Intelligent Multi-Knife Foam Cutting Machine,Multi-Knife Sponge Cutting Machine supplier & manufacturer, offer low price, high quality Cnc Multi-Knife Sponge Cutting Machine,Smart Blade Sponge Cutting Machine, etc.

Intelligent Multi-Knife Foam Cutting Machine,Multi-Knife Sponge Cutting Machine,Cnc Multi-Knife Sponge Cutting Machine,Smart Blade Sponge Cutting Machine

Dongguan Hengkun CNC Equipment Co.,Ltd , https://www.hkmsfoamcutter.com